Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
20%
Ph phase_3
1
20%
Ph phase_1
2
40%
Ph phase_2
1
20%

Phase Distribution

2

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Not yet recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (40.0%)
Phase 21 (20.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)

Trials by Status

not_yet_recruiting120%
completed240%
unknown120%
withdrawn120%

Recent Activity

0 active trials
Showing 5 of 5
withdrawnphase_1

Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation

NCT05453916
not_yet_recruitingphase_2

Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men

NCT05897034
completedphase_3

Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid Arthritis

NCT05480878
unknownphase_1

Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis

NCT03441893
completedphase_4

Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide

NCT04406246

Clinical Trials (5)

Showing 5 of 5 trials
NCT05453916Phase 1

Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation

Withdrawn
NCT05897034Phase 2

Combination Therapy Between Doxycycline, Pentoxifylline, and Nitazoxanide in Sexually Active Men

Not Yet Recruiting
NCT05480878Phase 3

Role of Nitazoxanide and Escitalopram in Patients With Rheumatoid Arthritis

Completed
NCT03441893Phase 1

Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis

Unknown
NCT04406246Phase 4

Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5